Personalis, Inc. is a cancer genomics company. The Company is focused on the development of therapies by providing molecular data about each patient’s cancer and immune response. The Company has designed NeXT Platform, which provides its biopharmaceu... Read more
MarketWatch
CNBC
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.